Making Sense of Next-Generation Sequencing Data
Missing the action at AGBT 2013 and want to know what is Illumina sequencing technology up to? Illumina has created special website for AGBT and shared a lot of interesting information. The Illumina website titled “Seek The Truth” has lot of information on Illumina technology and its usage. As a rebuttal to a recent report [...]
Illumina gave a glimpse of what to expect in the future on Illumina products at the Illumina user meeting on the first dat of AGBT 2013. One of the interesting updates from Illumina is that, it will offer Moleculo long read technology as s service first and will be available as a product later. Moleculo [...]
IonTorrent beats Illumina’s MiSeq again in the benchtop sequencing machine market, according to the latest report by Macquarie report. BioIT world reporting on the Macquarie’s analysis says that overall the benchtop sequencers market is led by IonTorrent with 62% of the benchtop sequencing market share and MiSeq with the remaining 38% of the market share. IonTorrent’s PGM has [...]
Illumina added Moleculo Technology to its technology page on its website. Illumina acquired the San Francisco based startup company founded by Stephen quake’s members Michael Kertesz and Dmitry Pushkarev in late 2012. All one initially knew was Moleculo Technology offers long reads using existing Illumina sequencers like HiSeq. After Plant and Animal Genomes conference, a bit [...]
Illumina announced the fourth quarter financial results yesterday. Illumina’s revenue during the fourth quarter of 2012 is $309 million, which is a 24% increase compared to the revenue of fourth quarter of 2011. Overall in the year 2012, Illumina’s revenue increased 9% from $1.06 billion in year 2011 to $1.15 billion in the year 2012. [...]
Xconomy’s Luke Timmerman interviewed Illumina CEO during last week’s JP Morgan Healthcare 2013 meeting and published the interview today at Xconmomy. The interview is a long one with Illumina’s CEO discussing a wide range of issues on next-gen sequencing including Illumina’s recent acquisitions Verinata Health and Moleculo. Here is a gist of the Illumin CEO’s comments on its recent acquisitions, [...]
Last week at the JMP 2013 Illumina announced the acquisition of San Francisco based Moleculo Inc. Moleculo, the company and its technology has been mysterious with little information known. All we know till now is that Moleculo is founded by Michael Kertesz and Dmitry Pushkarev, both alumini of Stephen Quake’s lab at Stanford. Moleculo has [...]
Illumina announced at the JP Morgan Healthcare Conference (JMP2013) that it has acquired San Francisco based Mocleculo. Moleculo, the sequencing startup company (with not much information in the web), is a product of Stanford University’s sequencing pioneer Stephen Quake. Michael Kertesz, a former postdoc at Stephen Quake’s lab, is the CEO and one of the co-founders [...]
Illumina announced a bunch of improvements one can expect in the future for its benchtop sequencer MiSeq and its big sequencer HiSeq 2500. Longer reads and more amount of data per run . Announcing the improvements at the JMP 2013, Illumina said its “new ordered array flow cell design will increase cluster density, enable higher [...]
